Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,547,612 papers from all fields of science
Search
Sign In
Create Free Account
propildazine
Known as:
3-hydrazino-6-((2-hydroxypropyl)methylamino)pyridazine
, PILDRALAZINE
, propyldazine
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Pyridazines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Carcinogenicity study in mice on pildralazine, a hydralazinelike antihypertensive compound
G. Porta
,
T. Dragani
Journal of Cancer Research and Clinical Oncology
2004
Corpus ID: 24019581
SummaryPildralazine, a hydralazinelike antihypertensive vasodilator containing a free hydrazine group, was administered in the…
Expand
1987
1987
Kinetic studies of the tissue binding tendency of the new vasodilator pildralazine.
E. Noack
,
W. Cawello
,
R. Bonn
Arzneimittel-Forschung
1987
Corpus ID: 30170811
Studies of the binding and release of the new antihypertensive drug (+/-)-1-[(6-hydrazinopyridazin-3-yl)methylamino]-2-propanol…
Expand
1986
1986
Effects of long-term administration of propyldazine on blood pressure and counter-regulatory systems in conscious hypertensive dogs.
G. Fischer
,
H. Stroißnig
,
N. Mayer
,
G. Krumpl
,
G. Raberger
Archives internationales de pharmacodynamie et de…
1986
Corpus ID: 30285000
The counter-regulatory effects in response to blood pressure reduction by propyldazine were studied in conscious dogs with…
Expand
1985
1985
Propyldazine is mutagenic in Salmonella typhimurium and Escherichia coli: distinct specificity for strains TA1537 and TA97.
H. Glatt
,
F. Oesch
Teratogenesis, carcinogenesis, and mutagenesis…
1985
Corpus ID: 21826791
The antihypertensive drug propyldazine (Atensil) was demonstrated to be mutagenic with auxotrophic mutants of Salmonella…
Expand
1985
1985
Characterization of vasodilators by comparison of their effects on blood pressure, counterregulation and myocardial oxygen demand in conscious normotensive dogs.
S. Bacher
,
O. Kraupp
,
A. Beck
,
H. Skoda
,
G. Raberger
Arzneimittel-Forschung
1985
Corpus ID: 41042026
Vasodilators were characterized on the basis of their first-dose effect on systolic and diastolic blood pressure, heart rate, on…
Expand
1984
1984
Effects of pildralazine alone and in combination on severe hypertension and cerebrovascular lesions in saline-drinking spontaneously hypertensive rats.
L. Dorigotti
,
C. Carpi
,
G. Bertoli
,
P. Mariani
Arzneimittel-Forschung
1984
Corpus ID: 23000897
The efficacy of long-term treatments with the vasodilator antihypertensive pildralazine alone and in combination with propranolol…
Expand
1984
1984
Altered blood pressure response to propyldazine after repeated oral administration in conscious normotensive dogs: role of the renin-angiotensin system
S. Bacher
,
O. Kraupp
,
A. Beck
,
R. Seitelberger
,
G. Raberger
Basic Research in Cardiology
1984
Corpus ID: 8017959
SummaryThe magnitude and the persistence of blood pressure reduction by propyldazine (PDZ) was investigated following treatment…
Expand
1981
1981
Degradation of propildazine in water.
P. Ventura
,
F. Parravicini
,
L. Simonotti
,
R. Colombo
,
G. Pifferi
Journal of Pharmacy and Science
1981
Corpus ID: 32510531
Propildazine degradation in water at pH 7.4 was studied under aerobic conditions. Three main products were isolated by column…
Expand
1979
1979
[Treatment of severe arterial hypertension with propyldazine (ISF 2123) associated with a diuretic and a beta-blocking agent].
P. Angelino
,
G. Lavezzaro
,
M. Carnovali
Minerva Cardioangiologica : a Journal on…
1979
Corpus ID: 32065853
1978
1978
Quantitative determination of propildazine in rat plasma by gas-liquid chromatography.
P. Ventura
,
M. Zanol
,
M. Visconti
,
G. Pifferi
Journal of Chromatography A
1978
Corpus ID: 31561192
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE